Tusq-D Cough Lozenges Orange Sugar Free

Introduction

Tusq-D are a medication that contains two active ingredients: Amylmetacresol and Dextromethorphan Hydrobromide. These lozenges are primarily used to provide relief from sore throat and cough associated with common cold or respiratory tract infections.

Uses

Tusq-D are indicated for the symptomatic relief of sore throat and dry, irritating cough caused by the common cold or respiratory tract infections. They can help soothe the throat and reduce coughing, allowing for improved comfort during a cold or infection.

Dosage and Administration

For adults and children over 12 years of age, the recommended dosage is one lozenge to be dissolved slowly in the mouth every three to four hours as needed. Follow the instructions on the packaging or as directed by your healthcare professional. Do not exceed the stated dose.

Mechanism of Action

Tusq-D work in two ways to alleviate sore throat and cough symptoms. Amylmetacresol has antiseptic properties that help reduce the growth of bacteria or other microorganisms in the throat, while Dextromethorphan Hydrobromide is a cough suppressant that acts on the cough center in the brain to reduce coughing.

Side Effects

Common side effects may include a mild burning or tingling sensation in the mouth, which is generally temporary and goes away on its own. Serious side effects are rare, but if you experience any severe allergic reactions, such as difficulty breathing or swelling of the face, lips, or tongue, seek medical attention immediately.

Drug Interactions

inform your healthcare professional about all the medications you are taking, including prescription, over-the-counter, and herbal products, before using Tusq-D. There are currently no known major drug interactions with these lozenges. However, it is always best to consult with your healthcare professional to ensure the safety and efficacy of combining medications.

Precautions

Before using Tusq-D, inform your healthcare professional if you have any known allergies to Amylmetacresol, Dextromethorphan Hydrobromide, or any other ingredients in the lozenges. Additionally, if you have any underlying medical conditions, such as asthma or chronic cough, or if you are pregnant or breastfeeding, it is advisable to consult with your healthcare professional before using this medication.

Storage

Tusq-D should be stored in a cool, dry place away from direct sunlight and out of reach of children. Follow the specific storage instructions provided on the packaging.

Patient Tips

• Allow the lozenge to dissolve slowly in your mouth, without chewing or swallowing it whole.
• Avoid eating or drinking for at least 30 minutes after using the lozenge to maximize its effectiveness.
• If your symptoms persist or worsen after a few days of using Tusq-D, consult your healthcare professional for further evaluation.
• Remember to read and follow the instructions on the packaging carefully.
• If you have any concerns or questions about using this medication, do not hesitate to speak with your healthcare professional for guidance.

Please note that this description, as well as the other content on our website is for educational purposes only. We do not provide medical advice. For specific medical advices, diagnoses and treatment options you should consult with your doctor.

References

• Hyoscine hydrobromide: medicine for travel sickness (NHS UK) [Accessed 15 Jun. 2024] (online) Available at:
• Boots Pharmaceuticals Sore Throat Relief Honey & Lemon Flavour 0.6 mg Lozenges (Health Professionals SmPC) Available at:
• Strepsils (International database) (Drugs.com) [Accessed 16 Jun. 2024] (online) Available at:
• Dextromethorphan and Quinidine (MedlinePlus) [Accessed 18 Jun. 2024] (online) Available at:
• Sundaraj S, Shariffuddin II, Chaw SH, Zakaria WAW, Ng KWS, Ruslan SR. Preoperative amylmetacresol and dichlorobenzyl alcohol with lignocaine lozenge reduces postoperative sore throat following general anaesthesia using supraglottic airway devices: A double-blinded, randomised, placebo-controlled trial. Indian J Anaesth. 2022 Jul;66(7):523-529. doi: 10.4103/ija.ija_809_21. Epub 2022 Jul 22. [Accessed 1 Jun. 2024] Available at: